FIELD: medicine.
SUBSTANCE: invention relates to immunology and pulmonology, and concerns activation factors antiviral protection in chronic obstructive pulmonary disease (COPD). That is ensured by single vaccination of patients with COPD, located outside aggravated disease with preparation "Prevenar-13".
EFFECT: method provides effective treatment of COPD with no side effects.
1 cl
Authors
Dates
2016-07-20—Published
2015-07-21—Filed